Novo Nordisk stock rises on strong sales of new weight-loss pill

Novo Nordisk's stock price increased following the company's announcement of higher guidance based on the strong sales performance of its weight-loss pill launched this year, MarketWatch reported.

The Danish pharmaceutical company attributed the positive outlook to the rapid adoption of the drug among consumers, signaling robust demand in the weight-loss market.

This development provided relief to investors who had been concerned about the company's recent performance, as the new product appears to be driving growth.

The company’s revised guidance reflects its confidence in continued strong sales momentum for the drug moving forward.